Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment. 2014/06
8.
原著
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment. 2014/07
9.
原著
Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C. 2014/08
10.
原著
Serum zinc value in patients with hepatitis virus-related chronic liver disease:association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. 2014/09
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment. 2015/01
16.
原著
A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. 2015/03
17.
原著
A new metabolism-related ndex correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. 2015/03
Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry. 2016/01
26.
原著
B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Inter feron-γ-Inducible Protein-10 in Autoimmune Hepatitis. 2016/03
27.
原著
Clinical implication of serum Wisteria floribunda Agglutinin-Positive Mac-2-binding protein in treatment naïve chronic hepatitis B. 2016/03
28.
原著
Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load. 2016/04
29.
原著
Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis 2016/05
30.
原著
Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis. 2016/05
31.
原著
improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment. 2016/05
32.
原著
Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level and high sensitivity C reactive protein concentration in autoimmune hepatitis. 2016/06
33.
原著
Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. 2016/07
34.
原著
A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation. 2016/08
35.
原著
Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis. 2016/09
36.
原著
Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients. 2016/10
37.
原著
Clinical significance of serum wisteria floribunda agglutinin-positive Mac-2-binding protein level in non-alcoholic steatohepatitis. 2016/11
38.
原著
An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients. 2016/12
39.
原著
Comparison of sleep disorders in chronic hepatitis C patients treated with interferon-based therapy and direct acting antivirals using actigraphy. 2016/12
40.
原著
Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study. 2016/12
41.
原著
Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients. 2016/12
42.
原著
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study. 2016/12
43.
原著
Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases. 2017/01
44.
原著
Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis. 2017/01
45.
原著
Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-po
sitive Mac-2-binding protein in chronic hepatitis C. 2017/03
46.
原著
Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices. 2017/05
47.
原著
Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices. 2017/06
48.
原著
Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis. 2017/06
49.
原著
Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis. 2017/06
50.
その他
Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for oesophageal varices: a study protocol for prospective interventional study. 2017/06
51.
原著
Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver Diseases. 2017/06
52.
原著
Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy. 2017/06
53.
その他
造影超音波検査による早期治療効果判定の検討 2017/06
54.
その他
Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: a study protocol for single-arm, prospective, interventional study. 2017/09
55.
その他
Efficacy of capsule endoscopy in patients with cirrhosis for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities: a study protocol for prospective interventional study. 2017/09
56.
その他
Sessyon1-3 造影超音波検査による早期治療効果判定の検討 2017/09
57.
原著
Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals. 2017/10
58.
原著
Development of a simple predictive model for decreased skeletal muscle mass in patients with compensated chronic liver disease. 2017/11
59.
原著
Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy. 2017/11
60.
原著
Prognostic significance of low skeletal muscle mass compared with protein-energy malnutrition in liver cirrhosis. 2017/11
61.
その他
Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial. 2017/12
62.
原著
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis. 2017/12
63.
原著
Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease. 2017/12
64.
その他
Clinical influence of exercise therapy on sarcopenia in patients with chronic pancreatitis: a study protocol for a randomised controlled trial. 2018/01
65.
原著
超音波減衰法"Attenuation imaging"による新しい脂肪肝診断. 2018/01
66.
その他
Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial. 2018/02
67.
その他
Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. 2018/02
68.
その他
Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial. 2018/02
69.
原著
Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response. 2018/05
70.
その他
造影超音波によるソラフェニブ早期治療効果判定とレゴラフェニブ移行へのタイミング. 2018/05
71.
原著
Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction. 2018/08
72.
原著
Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis. 2018/08
73.
原著
The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis. 2018/08
74.
総説
超高齢化時代の肝臓診療オーバービュー. 2018/10
75.
原著
Association of the Body Mass Index with the Presence of Gastroesophageal Varices in Compensated Cirrhotic Patients with Hepatitis C Viral Infection. 2018/11
76.
原著
Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases. 2018/12
77.
原著
Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength. 2018/12
78.
その他
Regorafenibの初期使用経験と造影超音波検査による治療効果判定. 2018/12
79.
原著
Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis B. 2019/03
80.
原著
Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases. 2019/03
Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases. 2019/05
83.
原著
Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis. 2019/06
84.
原著
Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices. 2019/06
85.
原著
Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases. 2019/07
86.
原著
Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases. 2019/09
87.
原著
Significant Correlation Between Grip Strength and m2bpgi in Patients with Chronic Liver Diseases. 2019/09
88.
原著
Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis. 2019/10
89.
原著
Serum Zinc Level Classification System: Usefulness in Patients with Liver Cirrhosis 2019/11
Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis. 2019/12
92.
原著
Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis. 2019/12
93.
原著
Serum zinc concentration and quality of life in chronic liver diseases. 2020/01
94.
原著
Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases. 2020/01
95.
原著
Walking Speed: Japanese Data in Chronic Liver Diseases. 2020/01
96.
原著
Serum Zinc Level Grading System: A Useful Model for Composite Hepatic Events in Hepatitis C Virus-Associated Liver Cirrhosis. 2020/02
97.
原著
Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases 2020/05
98.
原著
A New Ultrasonographic "Fluttering Sign" for Hepatic Hemangioma 2021/04
99.
原著
Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients 2021/04
Malignant grading system including the evaluation of kupffer function for hepatocellular carcinoma using Sonazoid contrast enhanced ultrasonography. (ポスター掲示,一般) 2013/09/24
Analysis of risk factors for aiming at early detection of hepatocellular carcinoma. (ポスター掲示,一般) 2013/11/04
27.
Spleen stiffness accurately predicts esophageal varices in patients with chronic liver disease regardless of the presence of portosystemic collaterals. (ポスター掲示,一般) 2013/11/04
28.
Usefulness and challenges associated with the spleen stiffness via Virtual Quantification for the prediction of liver fibrosis. (ポスター掲示) 2013/11/04
29.
HDGF(hepatoma-derived growth factor)-silencing inhibits the proliferation of hepatoma cells through a sorafenib-independent pathway. (ポスター掲示,一般) 2013/11/05
30.
The mitochondrial gene abnormalities and sustained pathological alterations in the liver after hepatitis C virus eradication (ポスター掲示,一般) 2013/11/05
Relationship between the mitochondria gene abnormality in liver tissues in patients with chronic viral hepatitis C and the hepatocarcinogenesis. (ポスター掲示) 2014/11
90.
Retrospective Cohort study for liver carcinogenesis prediction using VF map score : Virtual Touch Quantification(VTQ), Fasting blood glucose(FBG), male, age, platelet. (ポスター掲示) 2014/11
91.
Risk of esophageal varices predicted by share wave velocity. (ポスター掲示) 2014/11
92.
The pivotal role of anti-angiogenic activity in the in vivo antitumor effects of type I interferon. (ポスター掲示) 2014/11
93.
内視鏡治療より止血し得た胆管空腸吻合部静脈瘤の1例. (口頭,一般) 2014/11/15
94.
Feature of fibrosis diagnosis in hepatitis B patients. (口頭) 2014/11/20
The presence of histological abnormalities even after the elimination of hepatitis C virus (ポスター掲示,一般) 2015/11/14
140.
The relationship between the presence of esophageal varices and the Wisteria floribundaagglutinin-positive Mac-2-binding protein level in patients with Child-Pugh A liver cirrhosis. (ポスター掲示) 2015/11/14
141.
Usefulness of ultrasound elastography in assessing liver fibrosis in patients with chronic hepatitis and the difference of liver stiffness between HBV-related chronic hepatitis and non-HBV-related chronic hepatitis (ポスター掲示,一般) 2015/11/15
142.
Pssible involovement of hepatic steatosis in the elevation of aminotransferases in hepatitis B virusinfected patients who are HBeAg-negative and have low DNA levels. (ポスター掲示) 2015/11/16
143.
Usefulness of spleen stiffness measurement using VTQ in diagnosing esophagogastric varices including the relationship with collateral vessels. (ポスター掲示) 2015/11/16
144.
Retrospective cohort study for liver carcinogenesis prediction among HBs antigen negative and anti-HCV antibody negative hepatitis patients. (ポスター掲示) 2015/11/17
The diagnostic accuracy for liver fibrosis using shear wave elastography according to etiology of liver disease and the presence or absence of anti-viral therapy (ポスター掲示,一般) 2016/11/13
The unique patterns of change in the metabolic variables of patients with primary biliary cholangitis. (ポスター掲示) 2017/10/20
190.
The possible association between hepatic steatosis and decreased treatment efficacy in patients receiving sequential therapy for hepatitis B virus. (ポスター掲示) 2017/10/21
191.
Shear wave elastography for the diagnosis of esophagogastric varices (ポスター掲示,一般) 2017/10/31